COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 689: Articles 6881-6890  | Next

Outcome of COVID-19 in hospitalised immunocompromised patients: an analysis of the WHO ISARIC CCP-UK prospective cohort study.
Turtle, L., Thorpe, M., Drake, T. M., Swets, M., Palmieri, C., Russell, C. D., Ho, A., Aston, S., Wootton, D. G., Richter, A., de Silva, T. I., Hardwick, H. E., Leeming, G., Law, A., Openshaw, P. J., Harrison, E. M., Baillie, J. K., Semple, M. G., Docherty, A. B.
10.1101/2022.08.08.22278576 — Posted: 2022-08-11
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination
Jongkees, M. J., Geers, D., Hensley, K. S., Huisman, W., GeurtsvanKessel, C. H., Bogers, S., Gommers, L., Papageorgiou, G., Jochems, S. P., den Hollander, J. G., Schippers, E. F., Ammerlaan, H. S. M., Bierman, W. F. W., van der Valk, M., Berrevoets, M. A. H., Soetekouw, R., Langebeek, N., Bruns, A. H. W., Leyten, E. M. S., Sigaloff, K. C. E., van Vonderen, M. G. A., Delsing, C. E., Branger, J., Katsikis, P. D., Mueller, Y. M., de Vries, R. D., Rijnders, B. J. A., Brinkman, K., Rokx, C., Roukens, A. H. E.
10.1101/2022.08.10.22278577 — Posted: 2022-08-10
RapiD_AI: A framework for Rapidly Deployable AI for novel disease & pandemic preparedness
Youssef, A., Zhu, T., Thakur, A., Watkinson, P., Horby, P., W Eyre, D., A Clifton, D.
10.1101/2022.08.09.22278600 — Posted: 2022-08-10
An observational study on imported COVID-19 cases in Hong Kong during mandatory on-arrival hotel quarantine
Martin Sanchez, M., Wu, P., Adam, D., Yang, B., Lim, W. W., Lin, Y., Lau, E., Sullivan, S., Leung, G., Cowling, B. J.
10.1101/2022.08.09.22278572 — Posted: 2022-08-10
What rate of air filtration (ACH) can emulate protection of an N95 respirator in an unventilated room and how can it be checked?
Srikrishna, D.
10.1101/2022.08.09.22278555 — Posted: 2022-08-10
Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac(R), ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination
Chatsiricharoenkul, S., Niyomnaitham, S., Posen, H. J., Toh, Z. Q., Licciardi, P. V., Wongprompitak, P., Duangchinda, T., Pakchotanon, P., Chantima, W., Chokephaibulkit, K.
10.1101/2022.08.09.22278505 — Posted: 2022-08-10
Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Batra, R., Uni, R., Alvarez-Mulett, S., Gomez-Escobar, L. G., Patino, E., Hoffman, K., Simmons, W., Chetnik, K., Buyukozkan, M., Benedetti, E., Suhre, K., Schenck, E., Cho, S. J., Choi, A. M. K., Schmidt, F., Choi, M. E., Krumsiek, J.
10.1101/2022.08.10.22277939 — Posted: 2022-08-10
Early Detection of Emerging SARS-CoV-2 Variants of Interest for Experimental Evaluation
Wallace, Z. S., Davis, J., Niewiadomska, A. M., Olson, R. D., Shukla, M., Stevens, R., Zhang, Y., Zmasek, C. M., Scheuermann, R. H.
10.1101/2022.08.08.22278553 — Posted: 2022-08-10
Stability of SARS-CoV-2 in cold-chain transportation environments and the efficacy of disinfection measures
Peng, S., Li, G., Pathak, J. L., Guo, X., Lin, Y., Xu, H., Qiu, W., Zheng, J., Sun, W., Hu, X., Zhang, G., Li, B., Bi, X., Dai, J.
10.1101/2022.08.09.503429 — Posted: 2022-08-10
Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
Ren, P., Hu, Y., Peng, L., Yang, L., Suzuki, K., Fang, Z., Bai, M., Zhou, L., Feng, Y., Xiong, Y., Chen, S.
10.1101/2022.08.09.503414 — Posted: 2022-08-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).